Cargando…

Conceptual and terminological confusion around personalised medicine: a coping strategy

BACKGROUND: The idea of personalised medicine (PM) has gathered momentum recently, attracting funding and generating hopes as well as scepticism. As PM gives rise to differing interpretations, there have been several attempts to clarify the concept. In an influential paper published in this journal,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Grandis, Giovanni, Halgunset, Vidar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950113/
https://www.ncbi.nlm.nih.gov/pubmed/27431285
http://dx.doi.org/10.1186/s12910-016-0122-4
_version_ 1782443529618849792
author De Grandis, Giovanni
Halgunset, Vidar
author_facet De Grandis, Giovanni
Halgunset, Vidar
author_sort De Grandis, Giovanni
collection PubMed
description BACKGROUND: The idea of personalised medicine (PM) has gathered momentum recently, attracting funding and generating hopes as well as scepticism. As PM gives rise to differing interpretations, there have been several attempts to clarify the concept. In an influential paper published in this journal, Schleidgen and colleagues have proposed a precise and narrow definition of PM on the basis of a systematic literature review. Given that their conclusion is at odds with those of other recent attempts to understand PM, we consider whether their systematic review gives them an edge over competing interpretations. DISCUSSION: We have found some methodological weaknesses and questionable assumptions in Schleidgen and colleagues’ attempt to provide a more specific definition of PM. Our perplexities concern the lack of criteria for assessing the epistemic strength of the definitions that they consider, as well as the logical principles used to extract a more precise definition, the narrowness of the pool from which they have drawn their empirical data, and finally their overlooking the fact that definitions depend on the context of use. We are also worried that their ethical assumption that only patients’ interests are legitimate is too simplistic and drives all other stakeholders’ interests—including those that are justifiable—underground, thus compromising any hope of a transparent and fair negotiation among a plurality of actors and interests. CONCLUSION: As an alternative to the shortcomings of attempting a semantic disciplining of the concept we propose a pragmatic approach. Rather than considering PM to be a scientific concept in need of precise demarcation, we look at it as an open and negotiable concept used in a variety of contexts including at the level of orienting research goals and policy objectives. We believe that since PM is still more an ideal than an achieved reality, a plurality of visions is to be expected and we need to pay attention to the people, reasons and interests behind these alternative conceptions. In other words, the logic and politics of PM cannot be disentangled and disagreements need to be tackled addressing the normative and strategic conflicts behind them.
format Online
Article
Text
id pubmed-4950113
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49501132016-07-20 Conceptual and terminological confusion around personalised medicine: a coping strategy De Grandis, Giovanni Halgunset, Vidar BMC Med Ethics Debate BACKGROUND: The idea of personalised medicine (PM) has gathered momentum recently, attracting funding and generating hopes as well as scepticism. As PM gives rise to differing interpretations, there have been several attempts to clarify the concept. In an influential paper published in this journal, Schleidgen and colleagues have proposed a precise and narrow definition of PM on the basis of a systematic literature review. Given that their conclusion is at odds with those of other recent attempts to understand PM, we consider whether their systematic review gives them an edge over competing interpretations. DISCUSSION: We have found some methodological weaknesses and questionable assumptions in Schleidgen and colleagues’ attempt to provide a more specific definition of PM. Our perplexities concern the lack of criteria for assessing the epistemic strength of the definitions that they consider, as well as the logical principles used to extract a more precise definition, the narrowness of the pool from which they have drawn their empirical data, and finally their overlooking the fact that definitions depend on the context of use. We are also worried that their ethical assumption that only patients’ interests are legitimate is too simplistic and drives all other stakeholders’ interests—including those that are justifiable—underground, thus compromising any hope of a transparent and fair negotiation among a plurality of actors and interests. CONCLUSION: As an alternative to the shortcomings of attempting a semantic disciplining of the concept we propose a pragmatic approach. Rather than considering PM to be a scientific concept in need of precise demarcation, we look at it as an open and negotiable concept used in a variety of contexts including at the level of orienting research goals and policy objectives. We believe that since PM is still more an ideal than an achieved reality, a plurality of visions is to be expected and we need to pay attention to the people, reasons and interests behind these alternative conceptions. In other words, the logic and politics of PM cannot be disentangled and disagreements need to be tackled addressing the normative and strategic conflicts behind them. BioMed Central 2016-07-18 /pmc/articles/PMC4950113/ /pubmed/27431285 http://dx.doi.org/10.1186/s12910-016-0122-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
De Grandis, Giovanni
Halgunset, Vidar
Conceptual and terminological confusion around personalised medicine: a coping strategy
title Conceptual and terminological confusion around personalised medicine: a coping strategy
title_full Conceptual and terminological confusion around personalised medicine: a coping strategy
title_fullStr Conceptual and terminological confusion around personalised medicine: a coping strategy
title_full_unstemmed Conceptual and terminological confusion around personalised medicine: a coping strategy
title_short Conceptual and terminological confusion around personalised medicine: a coping strategy
title_sort conceptual and terminological confusion around personalised medicine: a coping strategy
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950113/
https://www.ncbi.nlm.nih.gov/pubmed/27431285
http://dx.doi.org/10.1186/s12910-016-0122-4
work_keys_str_mv AT degrandisgiovanni conceptualandterminologicalconfusionaroundpersonalisedmedicineacopingstrategy
AT halgunsetvidar conceptualandterminologicalconfusionaroundpersonalisedmedicineacopingstrategy